瑞普特罗
|
|
- CAS号:
- 54063-54-6
- 英文名:
- Reproterol
- 英文别名:
- D-1959;Reproterol;Brn 0590567;Einecs 258-956-1;13055-82-8 (Mono-hydrochloride);7-(3-((beta,3,5-Trihydroxyphenethyl)amino)propyl)theophylline;7-[3-[[2-(3,5-Dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]theophyline;7-(3-((2-(3,5-Dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)theophylline;7-[3-[(β,3,5-Trihydroxyphenethyl)amino]propyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione;1,2,3,6-Tetrahydro-1,3-dimethyl-7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)-2,6-purindion
- 中文名:
- 瑞普特罗
- 中文别名:
- 茶丙喘宁;瑞普特罗
- CBNumber:
- CB4875400
- 分子式:
- C18H23N5O5
- 分子量:
- 389.41
- MOL File:
- 54063-54-6.mol
|
|
|
瑞普特罗化学性质
-
熔点:
-
192-197°C (dec.)
-
|
-
沸点:
-
723.4±70.0 °C(Predicted)
-
|
-
密度:
-
1.47±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Refrigerator
-
|
-
溶解度:
-
Aqueous Base (Slightly), DMSO (Slightly)
-
|
-
酸度系数(pKa):
-
9.40±0.10(Predicted)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
Off-White to Dark Brown
-
|
瑞普特罗性质、用途与生产工艺
瑞普特罗为β2-受体兴奋剂,对β2-受体有较高选择性,对血管及心脏无明显作用,对支气管平滑肌的扩张作用,可解除支气管痉挛。其扩张支气管作用比羟喘强。气雾吸入后1分钟生效,口服30分钟生效,作用维持4~6小时。
静注:每次0.09mg,必要时10分钟后可重复给药。口服:每次10~20mg,每日3次。气雾吸入:每次0.5~1mg,一般连用2次,超过2次者疗效不佳。
1.本品静注宜缓慢给药,可出现心悸、震颤、烦躁、眩晕、头痛,但少见。
2.不宜与其他β-受体兴奋剂合用,避免增加不良反应。
3.甲状腺机能亢进、嗜铬细胞瘤、心肌梗死患者禁用。
瑞普特罗
上下游产品信息
上游原料
下游产品
瑞普特罗
生产厂家
全球有 18家供应商
瑞普特罗国内生产厂家
54063-54-6, 瑞普特罗 相关搜索:
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Heterocycles
- Aromatics
- Amines
- 平喘药物
- 茶丙喘宁
- 瑞普特罗
- 54063-54-6
- 1H-Purine-2,6-dione, 7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-3,7-dihydro-1,3-dimethyl-
- 7-[3-[[2-(3,5-Dihydroxyphenyl)-2-hydroxyethyl]aMino]propyl]-3,7-dihydro-1,3-diMethyl-1H-purine-2,6-dione
- Einecs 258-956-1
- Brn 0590567
- 7-(3-((beta,3,5-Trihydroxyphenethyl)amino)propyl)theophylline
- 7-(3-((2-(3,5-Dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)theophylline
- 13055-82-8 (Mono-hydrochloride)
- 1,2,3,6-Tetrahydro-1,3-dimethyl-7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)-2,6-purindion
- Reproterol
- D-1959
- 7-[3-[[2-(3,5-Dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]theophyline
- 7-[3-[(β,3,5-Trihydroxyphenethyl)amino]propyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione